Literature DB >> 27887890

Nonadditive Effects of Repetitive Administration of Lipoplexes in Immunocompetent Mice.

Jamie L Betker1, Thomas J Anchordoquy2.   

Abstract

Repetitive administration is routinely used to maintain therapeutic drug levels, but previous studies have documented an accelerated blood clearance of some lipid-based delivery systems under these conditions. To assess the effect of repetitive administration, non-PEGylated lipoplexes (+/-0.5) were administered 4 times via tail vein injection at 3-day intervals to immunocompetent BALB/c mice bearing 4T1 tumors. This study measured the effect of repeat administration of nontargeted lipoplexes on clearance, cytokine/chemokine response, plasmid distribution, reporter gene expression, and liver toxicity. We do not observe a refractory period or a statistically significant difference in blood clearance between the first administration and subsequent injections of this lipoplex formulation, consistent with the absence of a cytokine/chemokine response. However, we do see a significant effect on both plasmid accumulation and expression, an enhancement of 26-fold and 10-fold in tumor plasmid levels and expression, respectively, after 4 injections as compared to that after a single injection. In addition, in vivo imaging suggests that expression in other organs had diminished rapidly 72 h after each administration, in contrast to relatively constant expression in the tumor. Taken together, the findings indicate that gene delivery to tumors can be dramatically enhanced by employing repetitive administration.
Copyright © 2017 American Pharmacists Association®. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  biodistribution; cholesterol nanodomain; clearance; gene delivery; immunocompetent; lipoplex; liver toxicity; refractory period; repeat dosing; sphingosine

Mesh:

Substances:

Year:  2016        PMID: 27887890      PMCID: PMC5657239          DOI: 10.1016/j.xphs.2016.11.013

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  72 in total

1.  Cell cycle dependence of gene transfer by lipoplex, polyplex and recombinant adenovirus.

Authors:  S Brunner; T Sauer; S Carotta; M Cotten; M Saltik; E Wagner
Journal:  Gene Ther       Date:  2000-03       Impact factor: 5.250

Review 2.  Is endothelium the origin of endothelial progenitor cells?

Authors:  Mervin C Yoder
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-05-07       Impact factor: 8.311

3.  Activation of the human complement system by cholesterol-rich and PEGylated liposomes-modulation of cholesterol-rich liposome-mediated complement activation by elevated serum LDL and HDL levels.

Authors:  S Moein Moghimi; Islam Hamad; Rolf Bünger; Thomas L Andresen; Kent Jørgensen; A Christy Hunter; Lajos Baranji; Laszlo Rosivall; Janos Szebeni
Journal:  J Liposome Res       Date:  2006       Impact factor: 3.648

4.  Anti-PEG IgM elicited by injection of liposomes is involved in the enhanced blood clearance of a subsequent dose of PEGylated liposomes.

Authors:  XinYu Wang; Tatsuhiro Ishida; Hiroshi Kiwada
Journal:  J Control Release       Date:  2007-02-24       Impact factor: 9.776

5.  Accelerated blood clearance and altered biodistribution of repeated injections of sterically stabilized liposomes.

Authors:  E T Dams; P Laverman; W J Oyen; G Storm; G L Scherphof; J W van Der Meer; F H Corstens; O C Boerman
Journal:  J Pharmacol Exp Ther       Date:  2000-03       Impact factor: 4.030

6.  Increased endothelial cell turnover in areas of in vivo Evans Blue uptake in the pig aorta.

Authors:  B A Caplan; C J Schwartz
Journal:  Atherosclerosis       Date:  1973 May-Jun       Impact factor: 5.162

7.  Direct comparison of liposomal doxorubicin with or without polyethylene glycol coating in C-26 tumor-bearing mice: is surface coating with polyethylene glycol beneficial?

Authors:  R L Hong; C J Huang; Y L Tseng; V F Pang; S T Chen; J J Liu; F H Chang
Journal:  Clin Cancer Res       Date:  1999-11       Impact factor: 12.531

8.  Accumulation of liposomal lipid and encapsulated doxorubicin in murine Lewis lung carcinoma: the lack of beneficial effects by coating liposomes with poly(ethylene glycol).

Authors:  M J Parr; D Masin; P R Cullis; M B Bally
Journal:  J Pharmacol Exp Ther       Date:  1997-03       Impact factor: 4.030

9.  Stabilized plasmid-lipid particles containing PEG-diacylglycerols exhibit extended circulation lifetimes and tumor selective gene expression.

Authors:  E Ambegia; S Ansell; P Cullis; J Heyes; L Palmer; I MacLachlan
Journal:  Biochim Biophys Acta       Date:  2005-02-24

Review 10.  Potential induction of anti-PEG antibodies and complement activation toward PEGylated therapeutics.

Authors:  Johan J F Verhoef; John F Carpenter; Thomas J Anchordoquy; Huub Schellekens
Journal:  Drug Discov Today       Date:  2014-09-07       Impact factor: 7.851

View more
  4 in total

1.  The Use of Lactose as an Alternative Coating for Nanoparticles.

Authors:  Jamie L Betker; Thomas J Anchordoquy
Journal:  J Pharm Sci       Date:  2020-01-28       Impact factor: 3.534

2.  A novel method for conjugating the terminal amine of peptide ligands to cholesterol: synthesis iRGD-cholesterol.

Authors:  Matthew G Fete; Jamie L Betker; Richard K Shoemaker; Thomas J Anchordoquy
Journal:  Ther Deliv       Date:  2019-01

3.  The Effect of Repeat Administration of Lipoplexes on Gene Delivery, Biodistribution, and Cytokine Response in Immunocompetent Tumor-Bearing Mice.

Authors:  Jamie L Betker; Thomas J Anchordoquy
Journal:  J Pharm Sci       Date:  2021-12-18       Impact factor: 3.784

4.  Nanoparticle uptake by circulating leukocytes: A major barrier to tumor delivery.

Authors:  Jamie L Betker; Dallas Jones; Christine R Childs; Karen M Helm; Kristina Terrell; Maria A Nagel; Thomas J Anchordoquy
Journal:  J Control Release       Date:  2018-07-17       Impact factor: 9.776

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.